M. Krzystanek

发表

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Zoltan Szallasi, Ashish Chandra, Adam Huffman, 2018, Cell.

Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data

Z. Szallasi, A. Eklund, Qiyuan Li, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions

I Csabai, Z. Szallasi, I. Csabai, 2016, Oncogene.

Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions

I Csabai, Z. Szallasi, I. Csabai, 2016, Oncogene.

The genomic imprint of cancer therapies helps timing the formation of metastases

Z. Szallasi, I. Csabai, L. Reiniger, 2019, International journal of cancer.

[Evaluation of thrombocytosis as predictive factor in colorectal cancer].

Z. Szallasi, A. Eklund, A. Szász, 2013, Magyar sebeszet.

Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with

Z. Szallasi, I. Csabai, G. Tusnády, 2017 .

TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen

Zoltan Szallasi, Francesco Favero, Charles Swanton, 2015, BMC Medical Genomics.

The Genome of the Chicken DT40 Bursal Lymphoma Cell Line

Gábor E. Tusnády, Zoltan Szallasi, István Csabai, 2014, G3: Genes, Genomes, Genetics.

A comprehensive survey of the mutagenic impact of common cancer cytotoxics

Gábor E. Tusnády, Zoltan Szallasi, István Csabai, 2016, Genome Biology.

A clonal expression biomarker associates with lung cancer mortality

Angela E. Leek, Z. Szallasi, R. Booton, 2019, Nature Medicine.

Biasogram: Visualization of Confounding Technical Bias in Gene Expression Data

Z. Szallasi, A. Eklund, M. Krzystanek, 2013, PloS one.

Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor

Z. Szallasi, M. Krzystanek, Z. Baranyai, 2015, Pathology & Oncology Research.

Expression of Apolipoprotein B in the Kidney Attenuates Renal Lipid Accumulation*

M. Krzystanek, L. Nielsen, Tanja X Pedersen, 2010, The Journal of Biological Chemistry.

Prognostic and predictive markers in metastatic renal cell carcinoma.

Z. Szallasi, M. Gerlinger, J. Larkin, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers

Z. Szallasi, M. Dreze, A. Richardson, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut

Z. Szallasi, I. Csabai, G. Tusnády, 2017, BMC Bioinformatics.

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

Z. Szallasi, I. Csabai, J. Tímár, 2019, bioRxiv.

Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations

Z. Szallasi, I. Csabai, M. Freedman, 2020, Clinical Cancer Research.

Genomic aberration based molecular signatures efficiently characterize homologous recombination deficiency in prostate cancer

Z. Szallasi, I. Csabai, M. Freedman, 2019, bioRxiv.

Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer

Nicolai J. Birkbak, Z. Szallasi, I. Csabai, 2018, npj Breast Cancer.

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors

Z. Szallasi, I. Csabai, A. Eklund, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors

Z. Szallasi, I. Csabai, A. Eklund, 2018, bioRxiv.

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs

Z. Szallasi, A. Eklund, A. Richardson, 2015, Biomarker Research.

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs

Nicolai J. Birkbak, Z. Szallasi, A. Eklund, 2015, Biomarker Research.

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with distinct homologous recombination deficiency associated DNA aberration profiles

Z. Szallasi, I. Csabai, G. Klus, 2021, medRxiv.

Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer.

Henry W. Long, Z. Szallasi, S. Sukumar, 2015, Cell reports.

A robust prognostic gene expression signature for early stage lung adenocarcinoma

Zoltan Szallasi, Marcin Krzystanek, David Szüts, 2016, Biomarker Research.

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma

Z. Szallasi, T. Schumacher, J. Larkin, 2014, Cancer Immunology, Immunotherapy.

Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma

Z. Szallasi, A. Szallasi, M. Krzystanek, 2014, F1000Research.

Strand Orientation Bias Detector to determine the probability of FFPE sequencing artifacts

Anders Gorm Pedersen, Zoltan Szallasi, István Csabai, 2021, Briefings Bioinform..

Strand Orientation Bias Detector (SOBDetector) to remove FFPE sequencing artifacts

Anders Gorm Pedersen, Zoltan Szallasi, Miklos Diossy, 2018 .

Strand Orientation Bias Detector (SOBDetector) to remove artifacts from sequencing data of formalin fixed samples

Anders Gorm Pedersen, Zoltan Szallasi, Miklos Diossy, 2018 .

Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma

Z. Szallasi, T. Schumacher, J. Larkin, 2013 .

Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer.

Z. Szallasi, A. Eklund, M. Krzystanek, 2015, International journal of surgery.

The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer

Z. Szallasi, A. Eklund, M. Krzystanek, 2013, Thrombosis and Haemostasis.

Global Transcriptional Analysis of Bacillus licheniformis Reveals an Overlap between Heat Shock and Iron Limitation Stimulon

Thomas A. Poulsen, M. Rasmussen, I. Mijakovic, 2010, Journal of Molecular Microbiology and Biotechnology.

Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma

Z. Szallasi, A. Szallasi, M. Krzystanek, 2014, F1000Research.

Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut

Z. Szallasi, I. Csabai, G. Tusnády, 2017, BMC Bioinformatics.

Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data

Nicolai J. Birkbak, Z. Szallasi, A. Eklund, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma

Z. Szallasi, A. Szallasi, M. Krzystanek, 2014, F1000Research.

Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor

M. Krzystanek, B. Tihanyi, Ferenc Salamon, 2015, Pathology & Oncology Research.

Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer.

A. Eklund, M. Krzystanek, A. Zaránd, 2015, International journal of surgery.